<DOC>
	<DOCNO>NCT02148666</DOCNO>
	<brief_summary>One challenge stem cell therapy understand fate inject stem cell . By label various stem cell radioisotopes fate ( home ) demonstrate . In study , develop refine exist technique stem cell label various subtypes stem cell namely- freshly aspirate bone marrow cell , cryopreserved bone marrow cell , g-csf mobilized peripheral blood stem cell umbilical cord cell . After test label efficacy viability , cell inject coronary artery patient myocardial infarction undergone successful revascularization either angioplasty thrombolysis . Homing stem cell demonstrate nuclear scan procedure . We adapt technique use label cell detection infection bleed use nuclear scan vivo scan . Also use Technetium instead FDG little radioactivity allow u work current cardiac lab reconstruct labs special shield radioactive compound . Real benefit stem cell explore demonstrate proper homing .</brief_summary>
	<brief_title>Study Homing Labelled Stem Cells Human Heart .</brief_title>
	<detailed_description>Phase One : Four Different type stem cell test ( Freshly aspirate Bone marrow cell , cryopreserved cell , umbilical cord cell , Stem cell mobilise bone marrow g-csf , mesenchymal cell ) , efficacy label documented effect viability note . 3 sample type test result document . Different cell try test efficiency label technique different type cell . This provide protocols future label study . This conducted collaboration stem cell department , nuclear medicine department nuclear cardiology department . Phase Two ( Clinical Study ) : This pilot clinical study do alongside phase one study , enrol 10 patient Recent Myocardial infarction ( within 3 month ) . A small fraction patient 's bone marrow stem cell label Technetium 99m HMPAO . The labelled cell administer via intracoronary injection along unlabeled stem cell . The localization radio-labelled stem cell myocardium detect use conventional Gamma camera .</detailed_description>
	<criteria>Myocardial Infarction ( &lt; Three Months ) either angioplasty thrombolysis do open infarct cause artery . Patent coronary artery infarct Left ventricular dysfunction ( ejection fraction &lt; 50 % ) Ongoing infection Obstructive coronary disease History symptoms 3 month Any evidence malignancy systemic illness . Cell yield le 10 million cell</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>